| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/16/2011 | WO2011070568A1 Method for treating psoriasis |
| 06/16/2011 | WO2011070541A1 Cysteine protease inhibitors |
| 06/16/2011 | WO2011070539A1 Cysteine protease inhibitors |
| 06/16/2011 | WO2011070415A1 Novel therapeutic methods for treating inflammation and immune system disorders |
| 06/16/2011 | WO2011070278A2 Cosmetic or dermatological composition based on everlasting flower essential oil- and myrtle essential oil and the use thereof |
| 06/16/2011 | WO2011070168A1 Pharmaceutical composition for treating cutaneous burns |
| 06/16/2011 | WO2011070080A1 4- (azacycloalkyl) -benzene-1, 3 -diol derivatives as tyrosinase inhibitors and their synthesis and use thereof |
| 06/16/2011 | WO2011069184A1 Composition for treating skin lesions |
| 06/16/2011 | WO2011028567A4 Composition and method for skin repair |
| 06/16/2011 | WO2011014825A3 Antiangiogenic small molecules and methods of use |
| 06/16/2011 | US20110144565 Combination of a tiliroside and a peptide |
| 06/16/2011 | US20110144330 2,4-Pyrimidinediamine Compounds and their Uses |
| 06/16/2011 | US20110144316 Method for restructuring the epidermis using a polyol-glycoside composition |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144215 Bruise amelioration composition and method of use |
| 06/16/2011 | US20110144213 Anhydrous depigmenting compositions comprising a solubilized phenolic compound |
| 06/16/2011 | US20110144182 Treatment of surgical adhesions |
| 06/16/2011 | US20110144159 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors |
| 06/16/2011 | US20110144158 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 06/16/2011 | US20110144151 Novel process, salts, composition and use |
| 06/16/2011 | US20110144143 pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 06/16/2011 | US20110144141 Hair Growth and/or Regrowth Compositions |
| 06/16/2011 | US20110144138 Substituted pyrimido isoquinoline derivatives |
| 06/16/2011 | US20110144134 Anti-Inflammatory Pyrazolopyrimndines |
| 06/16/2011 | US20110144132 Substituted pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144130 Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methyl-penta-2,4-dienoic acid as a cosmetic |
| 06/16/2011 | US20110144122 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 06/16/2011 | US20110144114 Substituted triazinone derivatives |
| 06/16/2011 | US20110144104 Pyrrolidinyl-alkyl-amide derivatives, their preparation, and their therapeutic application as ccr3 receptor ligands |
| 06/16/2011 | US20110144102 Calcimimetic compound for use in the treatment of epithelial injury |
| 06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
| 06/16/2011 | US20110144084 6 substituted 2- heterocyclylamino pyrazine compounds as chk-1 inhibitors |
| 06/16/2011 | US20110144074 Caspase inhibitors and uses thereof |
| 06/16/2011 | US20110144068 3,4-diarylpyrazoles as protein kinase inhibitors |
| 06/16/2011 | US20110144060 Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods |
| 06/16/2011 | US20110144039 Antioxidative and hepatoprotective compositions containing diaryheptanoids from alnus japonica |
| 06/16/2011 | US20110144038 Human cd154-binding synthetic peptide and uses thereof |
| 06/16/2011 | US20110144027 Pharmaceutical compositions for promoting wound healing |
| 06/16/2011 | US20110144021 Therapeutic proteins from latex |
| 06/16/2011 | US20110144011 Cellular Activation Insulin Therapy |
| 06/16/2011 | US20110144003 Maintenance therapy regime/regimen for the treatment of acne |
| 06/16/2011 | US20110143995 Novel anti-allergic agents |
| 06/16/2011 | US20110143992 Methods and Compositions Related to GHS-R Antagonists |
| 06/16/2011 | US20110142948 Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy |
| 06/16/2011 | US20110142930 Pharmaceutical Compositions of Atorvastatin |
| 06/16/2011 | US20110142922 Stabilized composition and method for dermatological treatment |
| 06/16/2011 | US20110142918 Anti-angiogenic compositions and therapeutic applications thereof |
| 06/16/2011 | US20110142914 Inhalable compositions having enhanced bioavailability |
| 06/16/2011 | US20110142910 Clotting and Healing Compositions Containing Keratin Biomaterials |
| 06/16/2011 | US20110142907 Polymer for tissue bonding |
| 06/16/2011 | US20110142902 Hypoxia Inducing Factor (HIF) Stabilising Glasses |
| 06/16/2011 | US20110142896 Water-dispersible and multicomponent fibers from sulfopolyesters |
| 06/16/2011 | US20110142895 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
| 06/16/2011 | US20110142882 Control of blood flow in skin, subcutaneous tissue and muscle by botulinum toxin, snare protein mediating substances, and alpha adrenergic agents by either injection of transdermal delivery systems |
| 06/16/2011 | US20110142867 Immunotherapeutic methods and systems |
| 06/16/2011 | US20110142833 Methods for treating and preventing fibrosis |
| 06/16/2011 | US20110142832 Soluble tumor necrosis factor receptor treatment of medical disorders |
| 06/16/2011 | US20110142821 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 06/16/2011 | US20110142819 Method of improving would healing |
| 06/16/2011 | US20110142777 Use of indole compounds as a cosmetic |
| 06/16/2011 | US20110142773 Composition and periodical delivery system for cellular rejuvenation |
| 06/16/2011 | US20110142771 Photostabilization of Retinoids with Alkoxycrylene Compounds |
| 06/16/2011 | US20110142765 Novel phloroglucinol derivatives having selectin ligand activity |
| 06/16/2011 | US20110142761 Il-1 binding proteins |
| 06/16/2011 | DE102009058325A1 Extract of a plant of Brassica, useful for increasing antioxidant activity of epithelial tissue e.g. epithelial tissue of skin or preventing and treating eye diseases e.g. macular degeneration or cataract and preventing eating disorders |
| 06/16/2011 | CA2821513A1 Glycerine based jelly compositions |
| 06/16/2011 | CA2784928A1 Pharmaceutical composition for treating cutaneous burns |
| 06/16/2011 | CA2783612A1 Composition for treating skin lesions |
| 06/16/2011 | CA2782946A1 4- (azacycloalkyl) -benzene-1, 3 -diol derivatives as tyrosinase inhibitors and their synthesis and use thereof |
| 06/16/2011 | CA2782294A1 Cysteine protease inhibitors |
| 06/16/2011 | CA2782292A1 Cysteine protease inhibitors |
| 06/15/2011 | EP2333052A1 Desaturase genes and uses thereof |
| 06/15/2011 | EP2332990A1 Human anti-epidermal growth factor receptor antibody |
| 06/15/2011 | EP2332978A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332976A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332964A1 Apoptotically active peptides |
| 06/15/2011 | EP2332934A1 Chrystals including a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |
| 06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/15/2011 | EP2332578A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 06/15/2011 | EP2332566A1 IL-10 related peptides for wound healing |
| 06/15/2011 | EP2332558A1 Promotors of ceramide s generation |
| 06/15/2011 | EP2332555A2 Methods of using regenerative cells to promote wound healing |
| 06/15/2011 | EP2332550A1 Tetracyclines for the treatment of neurodegenerative diseases |
| 06/15/2011 | EP2332549A1 Novel tetracyclines and their use in medicine |
| 06/15/2011 | EP2332548A1 Tetracyclines for the treatment of stroke |
| 06/15/2011 | EP2332547A1 Tetracyclines for the treatment of inflammatory bowel disease |
| 06/15/2011 | EP2332546A1 Tetracyclines for the treatment of stroke |
| 06/15/2011 | EP2332541A1 Use of thioxanthine derivatives as MPO inhibitors |
| 06/15/2011 | EP2331521A1 Therapeutic compounds |
| 06/15/2011 | EP2331496A1 Use of an n-acyl amino acid selected from among n-palmitoyl alanine, n-palmitoyl glycine, and n-palmitoyl isoleucine as a regulating active agent of the genetic profile of senescent replicating fibroblasts of the human skin dermis |
| 06/15/2011 | EP2331209A1 Compositions for treating or alleviating skin diseases or disorders related to an enhanced level of anti-microbial peptides and proteins |
| 06/15/2011 | EP2331116A1 Anti-infective compounds and uses thereof |
| 06/15/2011 | EP2331065A1 Modified release emulsions for application to skin or vaginal mucosa |
| 06/15/2011 | EP2331056A1 Use of an n-acyl amino acid selected from among n-palmitoyl alanine, n-palmitoyl glycine, n-palmitoyl isoleucine, and n-cocoyl alanine as an active agent controlling the proportion of basal keratinocytes of the human skin epidermis and expressing the nuclear form of surviving, and anti-aging cosmetic composition comprising same |
| 06/15/2011 | EP2331052A2 Compositions comprising solid particles encapsulated in a cross-linked silicone matrix, and methods of making the same |
| 06/15/2011 | EP2331048A1 Oligomeric biosurfactants in dermatocosmetic compositions |
| 06/15/2011 | EP1717229B1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein |
| 06/15/2011 | EP1642981B1 RECOMBINANT GENE MEDICINE OF ADENOVIRUS VECTOR AND GENE p53 FOR TREATING PROLIFERATIVE DISEASES |